Endometriosis treated with lynestrenol.

article OA: closed CC0 ⤵ 17 in-corpus citations
View on OpenAlex View on PubMed
AI-generated summary by claude@2026-06, 2026-06-08

Lynestrenol treatment in 20 endometriosis patients showed benefit for 11 patients, with 7 experiencing no bleeding complications, but 8 required surgery due to treatment failure.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

20 patients with severe endometriosis who either had contraindications to operation or whose endometriosis recurred after operation were treated with Lynestrenol (LNL). In 8 cases the treatment failed after 6 weeks to 8 months and operation proved necessary. In 11 cases operative intervention has so far been unnecessary because of repeated LNL medication. The best results have been obtained in patients who have been treated for more than 2 years. Only 7 of the 20 patients had no bleeding complications. It is noted that if the symptoms either partly persist or recur in spite of LNL treatment for 9 to 12 months the patient and the doctor are more convinced that an operation is inevitable.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Lynestrenol Adult Cervix Mucus Cervix Mucus Endometriosis Endometriosis Endometriosis Female Humans Lynestrenol Lynestrenol Lynestrenol Pregnancy Uterine Hemorrhage Uterine Hemorrhage Vaginal Smears

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (17)

Source provenance

europepmc
last seen: 2026-08-09T06:10:49.860119+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-14T05:59:23.748286+00:00
License: CC0 · commercial use OK